Cellipont Bioservices to Manufacture Master Cell Bank for Secretome Therapeutics’ Lead Asset STM-01 Read more
Glox Therapeutics Secures Share of £3M Funding to Combat Antibiotic Resistance in Cystic Fibrosis Read more
FDA Approves SPRAVATO (esketamine) as First and Only Monotherapy for Treatment-Resistant Depression in Adults Read more
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe Read more
Dyne Therapeutics’ DYNE-101 Granted FDA Fast Track Designation for Myotonic Dystrophy Type 1 Read more
Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. Read more